Debut Plus

₹39.47

▼ -0.64 -1.60%

As of 10 Sept 2026 · delayed

BSE Listed

Sudarshan Pharma Industries Ltd. (543828)

Volume: 24,000Avg Vol 1W: 6,00,800Avg Vol 1M: 8,30,90952W Range:₹18.5₹42.79
BSE www.sudarshanpharma.com AI Report
Key Ratios
Checked just now
Market Cap₹985 Cr
Current Price₹39.47
Previous Close₹40.11
High / Low (52w)₹42.79 / ₹18.5
Volume24,000
Avg Vol (1W)6,00,800
Avg Vol (1M)8,30,909
Stock P/E39.08
Book Value₹6.82
Dividend Yield0%
ROE15.03%
ROA389.87%
Revenue (TTM)—
Revenue Growth—
Profit Margin343.2%
Total Debt—
Shares Outstanding25 Cr
Face Value—
EPS (TTM)₹1.01
P/B5.78
Debt / Equity1.13
50 DMA₹38.7
200 DMA₹30.61
Day change-1.60%
Price Chart
₹39.47▲ 25.38% · 1Y
₹42₹1938.0L
2025-09-11
2026-09-10

20-day avg volume: 6.5L shares

Pros
  • Healthy return on equity of 15.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 17% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹129 Cr₹116 Cr₹162 Cr₹145 Cr₹169 Cr₹168 Cr₹221 Cr₹174 Cr
EBITDA₹13 Cr₹8 Cr₹16 Cr₹11 Cr₹10 Cr₹11 Cr₹23 Cr₹16 Cr
Net Profit₹6 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹11 Cr₹6 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹116 Cr₹162 Cr₹508 Cr₹142 Cr₹167 Cr₹158 Cr₹200 Cr₹166 Cr
EBITDA₹8 Cr₹15 Cr₹40 Cr₹11 Cr₹11 Cr₹12 Cr₹21 Cr₹16 Cr
Net Profit₹3 Cr₹7 Cr₹16 Cr₹4 Cr₹4 Cr₹4 Cr₹10 Cr₹6 Cr
EPS——0.66—————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹58 Cr₹99 Cr₹138 Cr₹232 Cr₹283 Cr₹402 Cr
Total Liabilities₹38 Cr₹77 Cr₹108 Cr₹132 Cr₹171 Cr₹271 Cr
Equity₹20 Cr₹23 Cr₹30 Cr₹101 Cr₹112 Cr₹131 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹38 Cr
Investing₹-2 Cr₹-1 Cr₹-1 Cr₹-26 Cr₹-5 Cr₹-20 Cr
Financing₹0 Cr₹-1 Cr₹4 Cr₹66 Cr₹-12 Cr₹-14 Cr
Free Cash Flow₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹38 Cr
Shareholding
Promoter 58.93% Institutions 19.87% Public 21.2%
Efficiency & Working Capital
ROCE12.8%
Interest Coverage2.6
Dividend Payout—
Debtor Days116 d
Inventory Days102 d
Payable Days66 d
Cash Conversion Cycle151 d
Working Capital Days217 d
Shareholding Details

As of 2026-08-31

Promoter58.9%
FII19.9%
DII0%
Institutions19.9%
Public21.2%
Promoter Pledge0%
No. of Shareholders1,217
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodMar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026
Promoters57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%58.9%58.9%
FIIs3.6%1.4%1.4%13.1%18.5%19.5%20.8%19.8%19.9%19.4%19.9%
DIIs0%0%0%0%0%0%0%0%0%0%0%
Public39%41.2%41.2%29.5%24.2%23.1%21.8%22.8%22.7%21.7%21.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%1.4%0%
No. of Shareholders1,2449839137871,2121,3271,3831,4071,3461,2311,217
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sachin Vasantrai MehtaShareholding of Promoter and Promoter Group28.3%7.07 Cr
Hemal Vasantrai MehtaShareholding of Promoter and Promoter Group27.5%6.85 Cr
Multitude Growth Funds LimitedPublic Shareholding4.2%1.06 Cr
Century India Opportunity Fund PcPublic Shareholding3.2%81,00,000
Saumik Ketankumar DoshiPublic Shareholding2.6%65,52,000
Eminence Global Fund Pcc- Eubilia Capital Partners Fund IPublic Shareholding2%48,56,000
Ebisu Global Opportunities Fund LimitedPublic Shareholding1.9%48,00,000
Coeus Global Opportunities FundPublic Shareholding1.7%41,96,000
North Star Opportunities Fund Vcc-bull Value Incorporated Vcc Sub-fundPublic Shareholding1.7%41,12,000
Bridge India FundPublic Shareholding1.6%39,80,000
Nexpact LimitedPublic Shareholding1.5%37,36,000
Devangi Hemal MehtaShareholding of Promoter and Promoter Group0.9%22,94,070
Sachin V Mehta HufShareholding of Promoter and Promoter Group0.7%16,45,120
Namrata Sachin MehtaShareholding of Promoter and Promoter Group0.7%16,45,120
Hemal V Mehta HufShareholding of Promoter and Promoter Group0.7%16,45,120
Vasantray Ratilal MehtaShareholding of Promoter and Promoter Group0.2%4,93,190
Jatin Vasantrai MehtaShareholding of Promoter and Promoter Group0.1%1,64,470
Board of Directors
NameDesignationYear
Hemal V MehtaCMD & Director.2025
Sachin V MehtaED / Joint MD / CFO / Promoter2025
Umesh LuthraIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Rushabh Prashant PatilIndependent Non Exe. Director2025
ANIL BALKRISHNA GHOGARENon-Exec & Non-Independent Dir2025
NIRAV KISHOR KUMAR SHAHCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Chemical Division₹96 Cr68.7%
Pharmaceutical Division₹43 Cr31.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1352424
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025120052138
20254004412
20253002914
Company Information
Incorporated2008
ChairmanHemal V Mehta
AuditorNGST & Associates
Investor Email[email protected]
🌐 www.sudarshanpharma.com ↗

📍 301 3rd Floor Aura Biplex, SV Road Borivali(West), Mumbai, Maharashtra, 400092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

S. V. J. Enterprises LimitedAmanaya Ventures LimitedResGen LimitedITCONS E-Solutions LimitedDivgi Torqtransfer SystemsProspect Consumer Products Ltd.Labelkraft Technologies LimitedBright Outdoor Media LimitedCommand Polymers LimitedDev Labtech Venture LimitedDigital Fibre Infrastructure TrustJA Finance LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search